Physician
Tejinder S Randhawa MD INC
Tejinder S Randhawa MD INC was paid $1.80M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoTEJINDER S RANDHAWA MD INC
FRESNO, CA 93727
FRESNO, CA 93727
33aNPI1609970870assigned 09/11/2006
33bProvider typePediatrics Physician
28Total paid$1.80M
24GClaims504,285
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#81 of 1,490
Median peer was paid$15K
This provider vs. median120×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 50,067 | $256K | |
| 2019 | 88,540 | $303K | |
| 2020 | 66,107 | $214K | |
| 2021 | 63,397 | $266K | |
| 2022 | 80,077 | $201K | |
| 2023 | 87,821 | $281K | |
| 2024incomplete | 68,276 | $279K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 110,186 | 99,838 | $485K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 9.0% | 13,130 | 13,010 | $161K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.8% | 4,829 | 4,720 | $140K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.7% | 17,158 | 17,017 | $138K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.6% | 5,666 | 5,524 | $136K |
| G9920 | Screening performed and negative | 7.5% | 16,845 | 16,760 | $135K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.7% | 10,193 | 10,054 | $84K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4.3% | 13,013 | 12,903 | $78K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.0% | 21,766 | 21,683 | $54K |
| 96156 | 2.3% | 3,624 | 3,502 | $41K | |
| 92551 | 2.2% | 36,963 | 36,735 | $39K | |
| 0001A | 2.2% | 974 | 972 | $39K |
49 more codes
| 0002A | 2.0% | 891 | $36K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 5,756 | $27K |
| 90700 | <1% | 9,831 | $15K | |
| D1206 | Topical application of fluoride varnish | <1% | 9,140 | $15K |
| 90713 | <1% | 8,107 | $14K | |
| 90658 | <1% | 15,317 | $13K | |
| 90648 | <1% | 6,995 | $13K | |
| 90670 | <1% | 5,897 | $10K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,309 | $9K |
| 85018 | <1% | 49,448 | $9K | |
| 90680 | <1% | 2,976 | $7K | |
| 90744 | <1% | 4,021 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 733 | $7K |
| 90649 | <1% | 4,544 | $7K | |
| 90734 | <1% | 5,639 | $6K | |
| 90480 | <1% | 136 | $5K | |
| 90716 | <1% | 3,729 | $5K | |
| 83655 | <1% | 5,112 | $5K | |
| 90633 | <1% | 4,117 | $5K | |
| 90707 | <1% | 3,615 | $5K | |
| 90620 | <1% | 3,280 | $4K | |
| 86580 | <1% | 29,344 | $4K | |
| 91319 | <1% | 98 | $4K | |
| 99188 | <1% | 2,358 | $4K | |
| 91320 | <1% | 114 | $4K | |
| 81002 | <1% | 20,296 | $3K | |
| 90715 | <1% | 2,688 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,467 | $3K |
| 90651 | <1% | 3,554 | $3K | |
| 99384 | <1% | 40 | $3K | |
| 94010 | <1% | 2,149 | $2K | |
| 90677 | <1% | 796 | $2K | |
| 90657 | <1% | 2,344 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,497 | $2K |
| 0003A | <1% | 44 | $2K | |
| 99381 | <1% | 12 | $1K | |
| 94664 | <1% | 2,339 | $1K | |
| 91318 | <1% | 28 | $1K | |
| 90656 | <1% | 731 | $675.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 717 | $633.19 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 106 | $102.50 |
| 17000 | <1% | 27 | $69.80 | |
| 69210 | <1% | 77 | $45.36 | |
| 99173 | <1% | 4,142 | $29.46 | |
| 94060 | <1% | 42 | $26.75 | |
| 96127 | <1% | 586 | $24.05 | |
| 99177 | 0% | 15,600 | $0.00 | |
| 99072 | 0% | 137 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRANDHAWA, TEJINDER (PHYSICIAN/OWNER)
| Provider | Location | Paid |
|---|---|---|
| Tejinder S Randhawa MD INC | Fresno, CA | $501K |
| Tejinder S. Randhawa M.D., a Professional Corporation | Fresno, CA | $160K |
| Abby Medical Associates, INC. | Fresno, CA | $88K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.